BIOFRONTERA SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION TO FDA TO EXPAND AMELUZ® RED LIGHT PDT TO ACTINIC KERATOSES ON THE FULL BODY

Reuters · 1d ago

Please log in to view news